Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rose Anne, Leakan"'
Autor:
James B. Mitchell, Jane C. Atkinson, John A. Chiorini, Stephen M. Kaminsky, Songlin Wang, Ana P. Cotrim, Gabor G. Illei, Corinne M. Goldsmith, Jaime S. Brahim, Bruce J. Baum, Christine Delporte, Changyu Zheng, Rose Anne Leakan, Antonis Voutetakis, Carter Van Waes
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(8):1071-1077
The treatment of most patients with head and neck cancer includes ionizing radiation (IR). Salivary glands in the IR field suffer significant and irreversible damage, leading to considerable morbidity. Previously, we reported that adenoviral (Ad)-med
Autor:
Rodrigo F. Chuaqui, Benjamin S Wallis, Michael A. Tangrea, Michael R. Emmert-Buck, Vladimir Knezevic, Gallya Gannot, Rose Anne Leakan, John W. Gillespie, Heidi S. Erickson, Dan P. Hartmann
Publikováno v:
The Journal of Molecular Diagnostics. 7:427-436
High-throughput methods to detect and quantify antibodies in sera and other patient specimens have use for many clinical and laboratory studies, including those associated with cancer detection, microbial exposures, and autoimmune diseases. We develo
Autor:
Janine A. Smith, Vidya Sankar, Michael T. Brennan, Rose Anne Leakan, Margaret Grisius, Marc R. Kok, Sophie Ligier, Lida Radfar, Philip C. Fox, Albert Kingman, Stanley R. Pillemer
Publikováno v:
Arthritis Care & Research. 51:601-604
Objective To screen for potential efficacy and assess feasibility and safety of dehydroepiandrosterone (DHEA) as a treatment for Sjogren's syndrome (SS). Methods A 24-week randomized, double-blinded, pilot trial of oral DHEA (200 mg/day) versus place
Autor:
Janine A. Smith, Joan Manny, Bruce J. Baum, Rose Anne Leakan, Vidya Sankar, Stanley R. Pillemer, Michael T. Brennan, Marc R. Kok
Publikováno v:
Arthritis & Rheumatism. 50:2240-2245
Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjogren's syndrome (SS). Methods This pilot study was a 12-week randomized, double-blind, placebo-controlled trial of etanercept, with 14 subjects in each group.
Autor:
Amalia Dutra, Sharon Key, Evgenia Pak, A. John Barrett, Eva Mezey, Stanley R. Pillemer, Kenneth M. Yamada, Simon D. Tran, Michael J. Brownstein, Albert Kingman, Rose Anne Leakan, Bruce J. Baum
Publikováno v:
The Lancet. 361:1084-1088
Summary Background Adult bone marrow-derived (BMD) cells could be used to repair damaged organs and tissues, but the intrinsic plasticity of these cells has been questioned by results of in-vitro studies suggesting that such cells might fuse with oth
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 94:179-183
Objective. The purpose of this study was to determine whether systolic and diastolic blood pressures are associated with salivary flow, dry mouth, or dry eye symptoms in patients with primary Sjogren's syndrome as compared with xerostomic control sub
Autor:
William E. Wilkinson, Michael T. Brennan, David E. Kleiner, Bruce J. Baum, Rose Anne Leakan, Stanley R. Pillemer, Vidya Sankar, Jane C. Atkinson
Publikováno v:
Arthritis Care & Research. 47:189-195
Objective To investigate risk factors for positive minor salivary gland biopsy results in Sjogren's syndrome (SS) and dry mouth patients. Methods A total of 289 patients with dry mouth symptoms were evaluated. Potential risk factors for positive mino
Autor:
Niki M. Moutsopoulos, Vidya Sankar, Stanley R. Pillemer, Rose Anne Leakan, Sharon M. Wahl, Nikola Angelov
Publikováno v:
Annals of the Rheumatic Diseases. 65:112-114
Objective: To study the immunological consequences of systemic thalidomide treatment in patients with Sjogren’s syndrome. Methods: Cytokine (tumour necrosis factor α (TNFα), interleukin (IL) 6) and soluble receptor (sIL2R) levels were measured in
Autor:
Sharon M. Wahl, Nikola Angelov, Gikas E. Katsifis, Stanley R. Pillemer, Vidya Sankar, Rose Anne Leakan, Niki M. Moutsopoulos
Publikováno v:
Annals of the rheumatic diseases. 67(10)
To provide insight into the clinical failure of the tumour necrosis factor alpha (TNFalpha) inhibitor, etanercept, in primary Sjögren syndrome (pSS), an extensive analysis of the systemic immune profile of patients with pSS was carried out and the e
Autor:
Rose Anne Leakan, P. P. Tak, Marc R. Kok, Beatrijs M. Lodde, Vidya Sankar, Stanley R. Pillemer
Publikováno v:
Rheumatology (Oxford, England), 45(4), 481-484. Oxford University Press
Objectives. Altered lipid levels may occur in autoimmune diseases, for example low cholesterol levels have been described in rheumatoid arthritis (RA). Serum lipid profiles in patients with Sjogren's syndrome (SS) have not been investigated. We hypot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4715101bced307c7eab6c47ab5c0eed6
https://pure.amc.nl/en/publications/serum-lipid-levels-in-sjoegrens-syndrome(bf3b011c-f6d7-4d93-a795-624a0176d8a3).html
https://pure.amc.nl/en/publications/serum-lipid-levels-in-sjoegrens-syndrome(bf3b011c-f6d7-4d93-a795-624a0176d8a3).html